Sequence Specific Methylation of Ribonucleic Acid and Site-Specific Synthesis of Pseudouridines in Ribonucleic Acid

The Portal is a joint project of MATTO and the MTTC. The development and implementation of the portal has been paid for by the MTTC, Beth Israel Deaconess Medical Center, Boston Biomedical Research Institute, Boston University, Brandeis University, Caritas St. Elizabeth's Medical Center, Boston Children's Hospital, Dana Farber Cancer Institute, Harvard University, Joslin Diabetes Center, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, McLean Hospital, Northeastern University, The Schepens Eye Research Institute, and Tufts University.

Intellectual Property

ID:		UMA 97-27 and UMA 96-06
IP Type:		Licensable Technology
Title:		Sequence Specific Methylation of Ribonucleic Acid and Site-Specific Synthesis of Pseudouridines in Ribonucleic Acid
Inventor:		Maurille J. Fournier
Summary:		The mechanisms by which nucleotides in ribosomal RNA (rRNA) are selected for ribose methylation and pseudouridylation have been determined. Further, methods for methylation and pseudouridylation of RNAs at novel sites have been developed.
Tech Type:		Chemical Methods/Libraries and Chemistry and Materials \| Chemical Methods/Libraries and Chemistry and Materials
URL:		http://amherst.cvip-umass.net/index.cfm?fuseaction=tech.index
Contact:		Office of Commercial Ventures and Intellectual Property Phone: 413-545-3606 FAX: 413-545-3632 E-Mail: cvip@research.umass.edu
Organization:		University of Massachusetts at Amherst

Display all intellectual properties for Maurille J. Fournier
Display all intellectual properties for University of Massachusetts at Amherst